Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures

Aptamers that target a specific cell subpopulation within composite mixtures represent invaluable tools in biomedical research and in the development of cell-specific therapeutics. Here we describe a detailed protocol for a modular and generally applicable scheme to select aptamers that target the subpopulations of cells in which you are interested. A fluorescence-activated cell-sorting device is used to simultaneously differentiate and separate those subpopulations of cells having bound and unbound aptamers. There are fewer false positives when using this approach in comparison with other cell-selection approaches in which unspecific binding of nucleic acids to cells with reduced membrane integrity or their unselective uptake by dead cells occurs more often. The protocol provides a state-of-the-art approach for identifying aptamers that selectively target virtually any cell type under investigation. As an example, we provide the step-by-step protocol targeting CD19+ Burkitt's lymphoma cells, starting from the pre-SELEX (systematic evolution of ligands by exponential amplification) measurements to establish suitable SELEX conditions and ending at completion of the SELEX procedure, which reveals the enriched single-stranded DNA library.

[1]  G. Mayer,et al.  Evolution of specific RNA motifs derived from pan-protein interacting precursors. , 2010, Bioorganic & medicinal chemistry letters.

[2]  Mario Roederer,et al.  Quality assurance for polychromatic flow cytometry , 2006, Nature Protocols.

[3]  Michael Famulok,et al.  Molecular Recognition of Amino Acids by RNA-Aptamers: An L-Citrulline Binding RNA Motif and Its Evolution into an L-Arginine Binder , 1994 .

[4]  P. Burgstaller,et al.  Isolation of RNA Aptamers for Biological Cofactors by In Vitro Selection , 1994 .

[5]  D. Shangguan,et al.  Development of DNA aptamers using Cell-SELEX , 2010, Nature Protocols.

[6]  F. Ducongé,et al.  Metastasis‐focused cell‐based SELEX generates aptamers inhibiting cell migration and invasion , 2011, International journal of cancer.

[7]  M. Famulok,et al.  Generation and enzymatic amplification of high-density functionalized DNA double strands. , 2004, Angewandte Chemie.

[8]  D. Neri,et al.  Antibody-based targeting of the tumor vasculature. , 2007, Biochimica et biophysica acta.

[9]  J. M. Healy,et al.  Complex Target SELEX , 2008 .

[10]  Gerhard Ziemer,et al.  A New Technique for the Isolation and Surface Immobilization of Mesenchymal Stem Cells from Whole Bone Marrow Using High‐Specific DNA Aptamers , 2006, Stem cells.

[11]  D. Neri,et al.  An engineered antibody–interleukin‐12 fusion protein with enhanced tumor vascular targeting properties , 2006, International journal of cancer.

[12]  D. Patel,et al.  Adaptive recognition by nucleic acid aptamers. , 2000, Science.

[13]  G. Mayer,et al.  In vitro selection of ssDNA aptamers using biotinylated target proteins. , 2009, Methods in molecular biology.

[14]  D. S. Coffey,et al.  Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. , 2002, Cancer research.

[15]  Dario Neri,et al.  Engineering recombinant antibodies for immunotherapy , 1995, Cell Biophysics.

[16]  N. Becker,et al.  Sequence-specific binding of DNA and RNA to immobilized Nickel ions. , 2008, Biochemical and biophysical research communications.

[17]  Weihong Tan,et al.  Selection of DNA ligands for protein kinase C-delta. , 2006, Chemical communications.

[18]  Larry Gold,et al.  Proteomics and diagnostics: Let's Get Specific, again. , 2008, Current opinion in chemical biology.

[19]  M. Famulok,et al.  Prion‐Protein‐Specific Aptamer Reduces PrPSc Formation , 2002, Chembiochem : a European journal of chemical biology.

[20]  L. Cassiday,et al.  Crystal structure of NF-kappaB (p50)2 complexed to a high-affinity RNA aptamer. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Michael Famulok,et al.  RNA ligands that distinguish metabolite-induced conformations in the TPP riboswitch. , 2007, Angewandte Chemie.

[22]  Jeff Zimmerman,et al.  Crystal structure of NF-κB (p50)2 complexed to a high-affinity RNA aptamer , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Michael Famulok,et al.  Conformational changes in the expression domain of the Escherichia coli thiM riboswitch , 2007, Nucleic acids research.

[24]  Ying-Fon Chang,et al.  Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein* , 2001, The Journal of Biological Chemistry.

[25]  Gwendolyn M. Stovall,et al.  Technical and biological issues relevant to cell typing with aptamers. , 2009, Journal of proteome research.

[26]  Gerhard Ziemer,et al.  Streptavidin-coated magnetic beads for DNA strand separation implicate a multitude of problems during cell-SELEX. , 2009, Oligonucleotides.

[27]  T. Steitz,et al.  The structure of HIV‐1 reverse transcriptase complexed with an RNA pseudoknot inhibitor , 1998, The EMBO journal.

[28]  Michael Famulok,et al.  A versatile toolbox for variable DNA functionalization at high density. , 2005, Journal of the American Chemical Society.

[29]  M. Famulok,et al.  Secondary structures and functional requirements for thiM riboswitches from Desulfovibrio vulgaris, Erwinia carotovora and Rhodobacter spheroides , 2008, Biological chemistry.

[30]  J. McNamara,et al.  Cell-specific aptamers for targeted therapies. , 2009, Methods in molecular biology.

[31]  M. Famulok,et al.  An aptamer targeting the apical-loop domain modulates pri-miRNA processing. , 2010, Angewandte Chemie.

[32]  Bertrand Tavitian,et al.  Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase , 2005, PLoS biology.

[33]  Michael Famulok,et al.  A Y2 Receptor Mimetic Aptamer Directed against Neuropeptide Y* , 2002, The Journal of Biological Chemistry.

[34]  M. Famulok,et al.  Functionalized DNA: A New Replicable Biopolymer. , 2001, Angewandte Chemie.

[35]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[36]  M. Famulok,et al.  RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of beta-secretase BACE1 in vitro. , 2006, RNA.

[37]  H. Schluesener,et al.  Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels , 2001, The Journal of Biological Chemistry.

[38]  A. Ellington,et al.  Directed evolution of gold nanoparticle delivery to cells. , 2010, Chemical communications.

[39]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[40]  Michael Famulok,et al.  Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. , 2008, Angewandte Chemie.

[41]  D. Neri,et al.  Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy , 2008, Clinical Cancer Research.

[42]  Günter Mayer,et al.  From selection to caged aptamers: identification of light-dependent ssDNA aptamers targeting cytohesin. , 2009, Bioorganic & medicinal chemistry letters.

[43]  Michael Famulok,et al.  Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. , 2007, Chemical reviews.

[44]  Michael Famulok,et al.  In vivo-applied functional RNAs as tools in proteomics and genomics research. , 2002, Trends in biotechnology.

[45]  M. Lohse,et al.  An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro. , 2008, RNA.

[46]  P. Cramer,et al.  Structure of an RNA polymerase II–RNA inhibitor complex elucidates transcription regulation by noncoding RNAs , 2006, Nature Structural &Molecular Biology.

[47]  E. Gilboa,et al.  Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay , 2010, Nature.

[48]  Holden T Maecker,et al.  Flow cytometry controls, instrument setup, and the determination of positivity , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[49]  G. Mayer The chemical biology of aptamers. , 2009, Angewandte Chemie.

[50]  F. Eckstein,et al.  Modified oligonucleotides: synthesis and strategy for users. , 1998, Annual review of biochemistry.

[51]  Jack W. Szostak,et al.  An RNA motif that binds ATP , 1993, Nature.

[52]  D. Neri,et al.  Antibodies from phage display libraries as immunochemical reagents. , 1998, Methods in molecular biology.